Patent details

EN | LT

LT - 4-Metil-N-[3-(4-metil-imidazol-1-il)-5-trifluormetil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamido monohidrochlorido monohidrato druska

EN - MONOHYDROCHLORIDE MONOHYDRATE SALT OF 4-METHYL-N-[3-(4-METHYL-IMIDAZOL-1-YL)-5-TRIFLUOROMETHYL-PHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-BENZAMIDE

Legal status

Patent in force

Claims | Licences

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 401/14	(2006.01)
		A61K 31/506	(2006.01)
		A61P 35/00	(2006.01)

European patent
(11)	Number of the document	1910336
(13)	Kind of document	T
(96)	European patent application number	06787733.2
	Date of filing the European patent application	2006-07-18
(97)	Date of publication of the European application	2008-04-16
(45)	Date of publication and mention of the grant of the patent	2011-06-29
(46)	Date of publication of the claims translation	2011-10-25

PCT application
(86)	Number	PCT/US2006/027878
	Date	2006-07-18

PCT application publication
(87)	Number	WO 2007/015871
	Date	2007-02-08

Priority applications
(30)	Number	Date	Country code
	701406 P	2005-07-20	US
	716213 P	2005-09-12	US

Inventors
(72)	MANLEY, Paul, W., CH SHIEH, Wen-Chung, US SUTTON, Paul, Allen, US KARPINSKI, Piotr, H., US WU, Raeann, US MONNIER, Stéphanie, FR BROZIO, Jörg, CH

Grantee
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH

Attorney or representative
(74)	Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Title
(54)	4-Metil-N-[3-(4-metil-imidazol-1-il)-5-trifluormetil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamido monohidrochlorido monohidrato druska
	MONOHYDROCHLORIDE MONOHYDRATE SALT OF 4-METHYL-N-[3-(4-METHYL-IMIDAZOL-1-YL)-5-TRIFLUOROMETHYL-PHENYL]-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-BENZAMIDE

Last renewal fee
	Payment date	Validity (years)	Amount
	2025-06-18	20	347.00 EUR